×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Maravai LifeSciences Holdings Inc. (MRVI) NASDAQ

$8.72 0.14 (1.63%)

Market Cap: $1.14B

As of 03/28/24 03:46 PM EDT. Market open.

(MRVI)

Maravai LifeSciences Holdings Inc. (MRVI)
NASDAQ

$8.72
0.14 (1.63%)

Market Cap: $1.14B

As of 03/28/24 03:46 PM EDT. Market open.

Add to Portfolio

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate ... read more

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl W. Hull
Full Time Employees
125
URL
Address
10770 Wateridge Circle, Suite 200, CA, San Diego, 92121.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl W. Hull
Full Time Employees
125
Address
10770 Wateridge Circle, Suite 200, CA, San Diego, 92121.
PRICE CHART FOR MARAVAI LIFESCIENCES HOLDINGS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.54
Previous Close
$8.58
Days Range
$8.26 - $8.63
52 week range
$4.52 - $16.62
Volume
1,754,983
Avg. Volume (30 days)
2,593,301
Market Cap
$1.14B
Dividend Yield
-
P/E
(9.54)
Shares Outstanding
132,305,845
Open
$8.54
Previous Close
$8.58
Days Range
$8.26 - $8.63
52 week range
$4.52 - $16.62
Volume
1,754,983
Avg. Volume (30 days)
2,593,301
Market Cap
$1.14B
Dividend Yield
-
P/E
(9.54)
Shares Outstanding
132,305,845
FINANCIAL STATEMENTS FOR MARAVAI LIFESCIENCES HOLDINGS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MARAVAI LIFESCIENCES HOLDINGS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BUZZEO REBECCASee RemarksMar 15, 2024 Option Exercise$7.704,36633,618365,066Mar 18, 2024, 06:00 PM
ORESHACK KURTGeneral CounselMar 15, 2024 Option Exercise$7.704,55135,043223,349Mar 18, 2024, 05:59 PM
Dolan ChristineSee RemarksMar 15, 2024 Option Exercise$7.705,38341,449258,007Mar 18, 2024, 05:58 PM
Leddy Peter MichaelSee RemarksMar 15, 2024 Option Exercise$7.706,71451,698376,359Mar 18, 2024, 05:56 PM
Herde KevinChief Financial OfficerMar 15, 2024 Option Exercise$7.708,62466,405332,914Mar 18, 2024, 05:55 PM
HULL CARLSee RemarksMar 15, 2024 Option Exercise$7.7017,560135,212267,072Mar 18, 2024, 05:54 PM
ORESHACK KURTGeneral CounselFeb 15, 2024 Option Exercise$5.482,32212,725227,900Feb 20, 2024, 06:47 PM
Herde KevinChief Financial OfficerFeb 15, 2024 Option Exercise$5.482,66414,599341,538Feb 20, 2024, 06:47 PM
Dolan ChristineSee RemarksFeb 15, 2024 Option Exercise$5.481,94110,637263,390Feb 20, 2024, 06:46 PM
HULL CARLSee RemarksFeb 15, 2024 Option Exercise$5.4810,72958,795284,632Feb 20, 2024, 06:46 PM
Leddy Peter MichaelSee RemarksOct 31, 2023 Option Exercise$5.834492,618132,796Nov 16, 2023, 05:22 PM
Herde KevinChief Financial OfficerOct 31, 2023 Option Exercise$5.831,86110,85093,925Nov 16, 2023, 05:22 PM
Dolan ChristineSee RemarksOct 31, 2023 Option Exercise$5.831,72910,08075,727Nov 16, 2023, 05:21 PM
BUZZEO REBECCASee RemarksNov 15, 2023 Option Exercise$5.194,54923,60981,234Nov 16, 2023, 05:21 PM
MARTIN WILLIAM E. IIIChief Executive OfficerOct 16, 2023 Option Exercise$7.5466,197499,125281,858Oct 17, 2023, 05:12 PM
Herde KevinChief Financial OfficerApr 28, 2023 Option Exercise$11.7287410,24392,064Jul 19, 2023, 04:51 PM
ORESHACK KURTGeneral CounselApr 28, 2023 Option Exercise$11.721,01411,88463,370Jul 19, 2023, 04:51 PM
Dolan ChristineSee RemarksApr 28, 2023 Option Exercise$11.721,39416,33873,998Jul 19, 2023, 04:51 PM
Leddy Peter MichaelSee RemarksApr 28, 2023 Option Exercise$11.721,92022,502137,925Jul 19, 2023, 04:50 PM
Leddy Peter MichaelSee RemarksJul 17, 2023 Option Exercise$12.525,57869,837132,347Jul 19, 2023, 04:50 PM
Dolan ChristineSee RemarksFeb 15, 2023 Option Exercise$15.231,95629,79016,829Feb 17, 2023, 04:34 PM
NEEL BRIANSee RemarksFeb 15, 2023 Option Exercise$15.232,31235,21216,473Feb 17, 2023, 04:34 PM
HULL CARLChief Executive OfficerFeb 15, 2023 Option Exercise$15.239,719148,02071,881Feb 17, 2023, 04:33 PM
Herde KevinChief Financial OfficerFeb 15, 2023 Option Exercise$15.232,61139,76618,683Feb 17, 2023, 04:32 PM
ORESHACK KURTGeneral CounselFeb 15, 2023 Option Exercise$15.232,31235,21223,970Feb 17, 2023, 04:32 PM
NEEL BRIANSee RemarksOct 31, 2022 Option Exercise$14.113294,64218,785Nov 09, 2022, 05:39 PM
Herde KevinChief Financial OfficerOct 31, 2022 Option Exercise$14.114786,74521,294Nov 09, 2022, 05:35 PM
ORESHACK KURTGeneral CounselOct 31, 2022 Option Exercise$14.113514,95326,282Nov 09, 2022, 05:35 PM
ORESHACK KURTGeneral CounselApr 29, 2022 Option Exercise$22.953949,04225,931Jun 27, 2022, 07:55 PM
NEEL BRIANSee RemarksApr 29, 2022 Option Exercise$22.9557213,12718,456Jun 27, 2022, 07:55 PM
Herde KevinChief Financial OfficerApr 29, 2022 Option Exercise$22.954279,80020,816Jun 27, 2022, 07:55 PM
ORESHACK KURTGeneral CounselApr 29, 2022 Option Exercise$22.953949,04225,931Jun 27, 2022, 06:43 PM
Dolan ChristineSee RemarksApr 29, 2022 Option Exercise$22.9566615,28518,785Jun 27, 2022, 06:42 PM
Herde KevinChief Financial OfficerApr 29, 2022 Option Exercise$22.954279,80020,816Jun 27, 2022, 06:42 PM
NEEL BRIANSee RemarksApr 29, 2022 Option Exercise$22.9557213,12718,456Jun 27, 2022, 06:42 PM
Herde KevinChief Financial OfficerOct 31, 2021 Option Exercise$22.953928,996889Jan 27, 2022, 04:00 PM
Herde KevinChief Financial OfficerApr 30, 2021 Option Exercise$22.9549711,406497Jan 27, 2022, 04:00 PM
NEEL BRIANSee RemarksOct 31, 2021 Option Exercise$22.9559813,724884Jan 27, 2022, 04:00 PM
NEEL BRIANSee RemarksApr 30, 2021 Option Exercise$22.952866,564286Jan 27, 2022, 04:00 PM
ORESHACK KURTGeneral CounselOct 31, 2021 Option Exercise$22.9554212,4398,537Jan 27, 2022, 04:00 PM
ORESHACK KURTGeneral CounselApr 30, 2021 Option Exercise$22.9549511,3607,995Jan 27, 2022, 04:00 PM
Dolan ChristineSee RemarksOct 31, 2021 Option Exercise$22.952034,6591,119Jan 27, 2022, 04:00 PM
Dolan ChristineSee RemarksApr 30, 2021 Option Exercise$22.9591621,022916Jan 27, 2022, 04:00 PM
GTCR INVESTMENT XI LLCDirectorSep 09, 2021 Option Exercise$50.002,931,441146,572,05021,681,033Sep 13, 2021, 04:21 PM
GTCR INVESTMENT XI LLCDirectorApr 08, 2021 Option Exercise$31.25395,74412,367,00024,612,474Apr 09, 2021, 05:00 PM
GTCR INVESTMENT XI LLCDirectorApr 07, 2021 Option Exercise$31.252,638,29782,446,78125,008,218Apr 09, 2021, 05:00 PM
HULL CARLChief Executive OfficerNov 25, 2020 Buy$26.9435,000942,90035,000Nov 30, 2020, 04:34 PM
GTCR INVESTMENT XI LLCDirectorNov 24, 2020 Option Exercise$25.511,319,14833,658,06027,646,515Nov 27, 2020, 04:43 PM
GRAY SUSANNAHDirectorNov 24, 2020 Buy$27.0020,000540,00031,852Nov 25, 2020, 07:58 PM
SELLERS LISASee RemarksNov 24, 2020 Buy$27.0018,888509,97618,888Nov 25, 2020, 07:54 PM
Hance Robert BDirectorNov 24, 2020 Buy$27.0010,000270,00021,852Nov 25, 2020, 07:54 PM
PRAHALAD MURALIDirectorNov 24, 2020 Buy$27.0018,000486,00029,852Nov 25, 2020, 07:53 PM
LUCIER GREGORY TDirectorNov 24, 2020 Buy$27.0015,000405,00026,852Nov 25, 2020, 07:52 PM
Hopfield JessicaDirectorNov 24, 2020 Buy$27.0050,0001,350,00061,852Nov 25, 2020, 07:52 PM
ORESHACK KURTGeneral CounselNov 24, 2020 Buy$27.007,500202,5007,500Nov 25, 2020, 07:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BUZZEO REBECCASee Remarks03/15/202433,618
ORESHACK KURTGeneral Counsel03/15/202435,043
Dolan ChristineSee Remarks03/15/202441,449
Leddy Peter MichaelSee Remarks03/15/202451,698
Herde KevinChief Financial Officer03/15/202466,405
HULL CARLSee Remarks03/15/2024135,212
ORESHACK KURTGeneral Counsel02/15/202412,725
Herde KevinChief Financial Officer02/15/202414,599
Dolan ChristineSee Remarks02/15/202410,637
HULL CARLSee Remarks02/15/202458,795
Leddy Peter MichaelSee Remarks10/31/20232,618
Herde KevinChief Financial Officer10/31/202310,850
Dolan ChristineSee Remarks10/31/202310,080
BUZZEO REBECCASee Remarks11/15/202323,609
MARTIN WILLIAM E. IIIChief Executive Officer10/16/2023499,125
Herde KevinChief Financial Officer04/28/202310,243
ORESHACK KURTGeneral Counsel04/28/202311,884
Dolan ChristineSee Remarks04/28/202316,338
Leddy Peter MichaelSee Remarks04/28/202322,502
Leddy Peter MichaelSee Remarks07/17/202369,837
Dolan ChristineSee Remarks02/15/202329,790
NEEL BRIANSee Remarks02/15/202335,212
HULL CARLChief Executive Officer02/15/2023148,020
Herde KevinChief Financial Officer02/15/202339,766
ORESHACK KURTGeneral Counsel02/15/202335,212
NEEL BRIANSee Remarks10/31/20224,642
Herde KevinChief Financial Officer10/31/20226,745
ORESHACK KURTGeneral Counsel10/31/20224,953
ORESHACK KURTGeneral Counsel04/29/20229,042
NEEL BRIANSee Remarks04/29/202213,127
Herde KevinChief Financial Officer04/29/20229,800
ORESHACK KURTGeneral Counsel04/29/20229,042
Dolan ChristineSee Remarks04/29/202215,285
Herde KevinChief Financial Officer04/29/20229,800
NEEL BRIANSee Remarks04/29/202213,127
Herde KevinChief Financial Officer10/31/20218,996
Herde KevinChief Financial Officer04/30/202111,406
NEEL BRIANSee Remarks10/31/202113,724
NEEL BRIANSee Remarks04/30/20216,564
ORESHACK KURTGeneral Counsel10/31/202112,439
ORESHACK KURTGeneral Counsel04/30/202111,360
Dolan ChristineSee Remarks10/31/20214,659
Dolan ChristineSee Remarks04/30/202121,022
GTCR INVESTMENT XI LLCDirector09/09/2021146,572,050
GTCR INVESTMENT XI LLCDirector04/08/202112,367,000
GTCR INVESTMENT XI LLCDirector04/07/202182,446,781
HULL CARLChief Executive Officer11/25/2020942,900
GTCR INVESTMENT XI LLCDirector11/24/202033,658,060
GRAY SUSANNAHDirector11/24/2020540,000
SELLERS LISASee Remarks11/24/2020509,976
Hance Robert BDirector11/24/2020270,000
PRAHALAD MURALIDirector11/24/2020486,000
LUCIER GREGORY TDirector11/24/2020405,000
Hopfield JessicaDirector11/24/20201,350,000
ORESHACK KURTGeneral Counsel11/24/2020202,500
Load More Insider Transactions
FUNDS WITH A POSITION IN MARAVAI LIFESCIENCES HOLDINGS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
12 WEST CAPITAL MANAGEMENT LP11,602,9886.76%79.53%Growth
BLACKROCK INC.6,481,6680.00108%9.35%Other
AQR CAPITAL MANAGEMENT LLC3,504,1110.04%100.35%Other
RENAISSANCE TECHNOLOGIES LLC2,885,6890.03%8.5%Other
HOLOCENE ADVISORS, LP2,151,6560.09%ExitedGrowth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC1,768,0110.00121%3.7%Other
BAMCO INC /NY/1,483,6510.03%117.81%Growth At A Reasonable Price
D. E. SHAW & CO., INC.1,232,4990.00705%60.22%Other
BALYASNY ASSET MANAGEMENT L.P.495,4260.00609%-14.21%Event Driven
GOTHAM ASSET MANAGEMENT, LLC524,9130.06%0.17%Other
CHANGE IN SHARES OUTSTANDING FOR MARAVAI LIFESCIENCES HOLDINGS INC
STOCK BUYBACKS FOR MARAVAI LIFESCIENCES HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.16%
1Q
12/31/2023
06/30/2023
0.21%
2Q
12/31/2023
03/31/2023
0.31%
3Q
12/31/2023
12/31/2022
-48.25%
4Q
12/31/2023
09/30/2022
0.37%
5Q
12/31/2023
06/30/2022
-48.25%
6Q
12/31/2023
03/31/2022
-48.24%
7Q
12/31/2023
12/31/2021
-48.75%
8Q
12/31/2023
09/30/2021
-48.79%
9Q
12/31/2023
06/30/2021
17.69%
10Q
12/31/2023
03/31/2021
36.69%
11Q
12/31/2023
09/30/2020
-47.96%
13Q
12/31/2023
06/30/2020
-47.96%
14Q
12/31/2023
03/31/2020
-47.96%
15Q
12/31/2023
12/31/2019
-47.96%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.16%
1Q
06/30/2023
0.21%
2Q
03/31/2023
0.31%
3Q
12/31/2022
-48.25%
4Q
09/30/2022
0.37%
5Q
06/30/2022
-48.25%
6Q
03/31/2022
-48.24%
7Q
12/31/2021
-48.75%
8Q
09/30/2021
-48.79%
9Q
06/30/2021
17.69%
10Q
03/31/2021
36.69%
11Q
09/30/2020
-47.96%
13Q
06/30/2020
-47.96%
14Q
03/31/2020
-47.96%
15Q
12/31/2019
-47.96%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MARAVAI LIFESCIENCES HOLDINGS INC
LOADING...